These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 20433742

  • 1. Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.
    Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J.
    Mol Cancer; 2010 Apr 30; 9():96. PubMed ID: 20433742
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W, McLeod HL, Cassidy J, Collie-Duguid ES.
    Cancer Chemother Pharmacol; 2007 May 30; 59(6):839-45. PubMed ID: 17119966
    [Abstract] [Full Text] [Related]

  • 7. Resistance to tomudex (ZD1694): multifactorial in human breast and colon carcinoma cell lines.
    Drake JC, Allegra CJ, Moran RG, Johnston PG.
    Biochem Pharmacol; 1996 May 17; 51(10):1349-55. PubMed ID: 8787551
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.
    Mishra PJ, Song B, Mishra PJ, Wang Y, Humeniuk R, Banerjee D, Merlino G, Ju J, Bertino JR.
    PLoS One; 2009 Dec 24; 4(12):e8445. PubMed ID: 20041160
    [Abstract] [Full Text] [Related]

  • 10. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase.
    Banerjee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR.
    Biochim Biophys Acta; 2002 Jul 18; 1587(2-3):164-73. PubMed ID: 12084458
    [Abstract] [Full Text] [Related]

  • 11. miR-192 Regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit.
    Song B, Wang Y, Kudo K, Gavin EJ, Xi Y, Ju J.
    Clin Cancer Res; 2008 Dec 15; 14(24):8080-6. PubMed ID: 19088023
    [Abstract] [Full Text] [Related]

  • 12. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
    Serra M, Reverter-Branchat G, Maurici D, Benini S, Shen JN, Chano T, Hattinger CM, Manara MC, Pasello M, Scotlandi K, Picci P.
    Ann Oncol; 2004 Jan 15; 15(1):151-60. PubMed ID: 14679136
    [Abstract] [Full Text] [Related]

  • 13. Isolation and characterization of a mutant dihydrofolate reductase-thymidylate synthase from methotrexate-resistant Leishmania cells.
    Arrebola R, Olmo A, Reche P, Garvey EP, Santi DV, Ruiz-Perez LM, Gonzalez-Pacanowska D.
    J Biol Chem; 1994 Apr 08; 269(14):10590-6. PubMed ID: 8144647
    [Abstract] [Full Text] [Related]

  • 14. Combined gene deletion of dihydrofolate reductase-thymidylate synthase and pteridine reductase in Leishmania infantum.
    Bhattacharya A, Leprohon P, Ouellette M.
    PLoS Negl Trop Dis; 2021 Apr 08; 15(4):e0009377. PubMed ID: 33905412
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.
    Longley DB, Ferguson PR, Boyer J, Latif T, Lynch M, Maxwell P, Harkin DP, Johnston PG.
    Clin Cancer Res; 2001 Nov 08; 7(11):3533-9. PubMed ID: 11705873
    [Abstract] [Full Text] [Related]

  • 16. Retroviral transduction of a mutant dihydrofolate reductase-thymidylate synthase fusion gene into murine marrow cells confers resistance to both methotrexate and 5-fluorouracil.
    Capiaux GM, Budak-Alpdogan T, Takebe N, Mayer-Kuckuk P, Banerjee D, Maley F, Bertino JR.
    Hum Gene Ther; 2003 Mar 20; 14(5):435-46. PubMed ID: 12691609
    [Abstract] [Full Text] [Related]

  • 17. miR-29 Family Inhibits Resistance to Methotrexate and Promotes Cell Apoptosis by Targeting COL3A1 and MCL1 in Osteosarcoma.
    Xu W, Li Z, Zhu X, Xu R, Xu Y.
    Med Sci Monit; 2018 Dec 06; 24():8812-8821. PubMed ID: 30518744
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.